Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60137-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850268664851333120 |
|---|---|
| author | Yong Wang Yanan Wang Lei Bao Goncalo Vale Jeffrey G. McDonald Yisheng Fang Yan Peng Ashwani Kumar Chao Xing Fara Brasó-Maristany Aleix Prat Carlos L. Arteaga Yingfei Wang Weibo Luo |
| author_facet | Yong Wang Yanan Wang Lei Bao Goncalo Vale Jeffrey G. McDonald Yisheng Fang Yan Peng Ashwani Kumar Chao Xing Fara Brasó-Maristany Aleix Prat Carlos L. Arteaga Yingfei Wang Weibo Luo |
| author_sort | Yong Wang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fe54f6efac7744328ceab8e327232e65 |
| institution | OA Journals |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-fe54f6efac7744328ceab8e327232e652025-08-20T01:53:23ZengNature PortfolioNature Communications2041-17232025-05-011611110.1038/s41467-025-60137-1Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27Yong Wang0Yanan Wang1Lei Bao2Goncalo Vale3Jeffrey G. McDonald4Yisheng Fang5Yan Peng6Ashwani Kumar7Chao Xing8Fara Brasó-Maristany9Aleix Prat10Carlos L. Arteaga11Yingfei Wang12Weibo Luo13Department of Pathology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterCenter for Human Nutrition, UT Southwestern Medical CenterCenter for Human Nutrition, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterEugene McDermott Center for Human Growth and Development, UT Southwestern Medical CenterEugene McDermott Center for Human Growth and Development, UT Southwestern Medical CenterTranslational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical Centerhttps://doi.org/10.1038/s41467-025-60137-1 |
| spellingShingle | Yong Wang Yanan Wang Lei Bao Goncalo Vale Jeffrey G. McDonald Yisheng Fang Yan Peng Ashwani Kumar Chao Xing Fara Brasó-Maristany Aleix Prat Carlos L. Arteaga Yingfei Wang Weibo Luo Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 Nature Communications |
| title | Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 |
| title_full | Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 |
| title_fullStr | Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 |
| title_full_unstemmed | Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 |
| title_short | Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 |
| title_sort | publisher correction zmynd8 drives her2 antibody resistance in breast cancer via lipid control of il 27 |
| url | https://doi.org/10.1038/s41467-025-60137-1 |
| work_keys_str_mv | AT yongwang publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT yananwang publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT leibao publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT goncalovale publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT jeffreygmcdonald publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT yishengfang publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT yanpeng publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT ashwanikumar publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT chaoxing publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT farabrasomaristany publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT aleixprat publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT carloslarteaga publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT yingfeiwang publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 AT weiboluo publishercorrectionzmynd8drivesher2antibodyresistanceinbreastcancervialipidcontrolofil27 |